http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ZA-200104071-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47535fe04804c5e73983c0e734e86ed2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c76c585e8c90bd24cd8bc145fa6c932
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
filingDate 2001-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b50c44c70d55f3a6c4b6a2b44b17adcf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e471af58ba60e4b6e0534f26b689b65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_025ae4892586d67579f543def54b3c47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff34143f8f7cc560d2e0fda15429c998
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e72585732d45f623265a522d10ed721
publicationDate 2003-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ZA-200104071-B
titleOfInvention Quinoline-4-carboxamide derivatives as NK-3 and NK-2 receptor antagonists.
priorityDate 1998-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID282088
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424636668
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3753329
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID21337
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100009175
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID6865
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID101839819
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100720631
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100002125

Total number of triples: 25.